Bioscience Animal Health PCL (BKK:BIS) EV-to-EBIT : 13.39 (As of May. 16, 2024)

Bioscience Animal Health PCL EV-to-EBIT Chart

Bioscience Animal Health PCL Quarterly Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial										29.06	33.37	29.31	24.96	21.36

Competitive Comparison of Bioscience Animal Health PCL's EV-to-EBIT

For the Packaged Foods subindustry, Bioscience Animal Health PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioscience Animal Health PCL's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioscience Animal Health PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bioscience Animal Health PCL's EV-to-EBIT falls into.

Bioscience Animal Health PCL EV-to-EBIT Calculation

Bioscience Animal Health PCL's EV-to-EBIT for today is calculated as:

Bioscience Animal Health PCL's current Enterprise Value is ฿914 Mil.
Bioscience Animal Health PCL's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioscience Animal Health PCL  (BKK:BIS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bioscience Animal Health PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Bioscience Animal Health PCL's Enterprise Value for the quarter that ended in Dec. 2023 was ฿1,458 Mil.
Bioscience Animal Health PCL's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioscience Animal Health PCL EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bioscience Animal Health PCL's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioscience Animal Health PCL (BKK:BIS) Business Description